Could not find what you are looking for?
Apollo News (1072)
Clinical Excellence
Indraprastha Apollo Hospitals, Delhi has successfully performed a life-saving liver transplant on a 5-month-ol...
In an extremely rare case of Budd Chiari Syndrome with Biliary Atresia, doctors at Indraprastha Apollo Hospitals, Delhi saved the life of a 5-month-old baby girl Surampudi Sehitha from Kakinada, Andhra Pradesh. The baby developed jaundice when she was just one month old. Her condition worsened as her abdomen started distending due to progressive swelling.
Dr Anupam Sibal, Group Medical Director and Senior Pediatric Gastroenterologist and Hepatologist, Apollo Hospitals Group said, “In Biliary Atresia, which is seen 1 in 12000 babies there is no connection between the liver and the intestine. The first step in treatment is to create a connection between the liver and the intestine. This was attempted at the local hospital initially to treat the baby’s condition but as Baby Surampudi’s liver was already severely shrunken (due to cirrhosis), the procedure was abandoned. She was further referred to Apollo Hospitals, Delhi for a liver transplant.”
“She weighed 5.5 kg when she first came to our hospital, including abdominal fluid of about 1 litre. So effectively, her weight was 4.5 kg. CT Angiography showed that she was suffering from occluded hepatic venous channels which drain the liver. The diagnosis of Budd Chiari Syndrome was made. It is a very rare disease which afflicts 1 in 2 million children. Budd Chiari Syndrome had resulted in rapid worsening of the baby’s condition which necessitated an urgent liver transplant. While Biliary Atresia is the most common condition for which liver transplantation in children are performed, Budd Chiari syndrome is extremely rare. Of the 320 liver transplants that we have performed in children, more than 140 have been for children with Biliary Atresia. The combination of Budd Chiari syndrome with Biliary Atresia in a baby is the rarest of rare case” Dr Sibal added.
Baby Surampudi underwent a living donor liver transplant on 25th March, 2019 with her mother being her donor. Dr Neerav Goyal, Senior Consultant liver transplant and Hepatobiliary and Pancreatic surgeon, Apollo Hospitals Group, explained, “A combination of Budd Chiari and Biliary Atresia made the liver transplant very high risk. The blood vessels in a baby are very small (3-4 mm) and with Budd Chiari Syndrome the risk of clotting in the blood vessels is increased. We explained the procedure to the parents in detail and counselled them so that they make an informed decision. Initially, the father was worked up as the donor but his liver was found unsuitable for donation. The mother’s liver turned out to be compatible. After her surgery, Baby Surampada, recovered well and was discharged after three weeks. Today, she is on medications to prevent re-occlusion of her tiny vessels and to prevent rejection of the transplanted liver.”
“As the family had limited resources, they received financial help from many benevolent people who came forward to contribute for her treatment through a crowd-funding platform” he added. The parents of the child said, “Having to watch our newly born in so much pain and is one of the toughest burdens that we had to bear as parents. However, doctors at Apollo Hospitals did not let our confidence shatter and worked dedicatedly to save the life of our baby girl. We are extremely thankful to the team of doctors at Apollo Hospitals as well as the people who came forward to help us out financially through this tough time. Our baby is alive and well, thanks to the kindness of many strangers.”
The team included, Dr. Shishir Parikh, Liver Transplant and Pancreatic surgeon, Dr. V Arun Kumar, Liver Transplant and Pancreatic surgeon, Dr. Hitender Garg, Gastroenterologist and Hepatologist, Dr Namit Jerath, Pediatric Intensivist and Dr. Smita Malhotra, Pediatric Gastroenterologist and Hepatologist.
Technology
Dr. Prathap C Reddy, Founder and Chairman – Apollo Hospitals inaugurates South Asia’s First Digita...
Apollo Hospitals introduces the first of its kind Digital PET CT – Biograph Vision 600™ scanning machine. The state-of-the-art scanning machine is a radioactive diagnostic agent used in positron emission tomography (PET) imaging. The inauguration was done in the presence of Dr. Prathap C Reddy, Founder and Chairman – Apollo Hospitals, Ms. Suneeta Reddy, Managing Director, Apollo Hospitals Group and Mr. Vivek Kanade, Executive Director, Siemens Healthineers India.
Know more about Digital PET CT – Biograph Vision 600™
Clinical Excellence
Apollo Proton Cancer Centre, Chennai has successfully performed India’s first Total Marrow Irradiation P...
Apollo Proton Cancer Center, Chennai brings the best and latest medical technology in India, by successfully performing India’s first Total Marrow Irradiation (TMI) as a conditioning protocol prior to Bone Marrow Transplant on a 35-year-old female patient from Oman.
Read more about India’s first Total Marrow Irradiation (TMI)
Milestones
Apollo Hospitals, Guwahati successfully performed Guwahati’s first ever Minimally Invasive Cardiac Surge...
Apollo Hospitals, Guwahati was the first hospital in Guwahati to perform Minimally Invasive Cardiac Surgery on March 7, 2019. A team of experts headed by renowned Cardio Thoracic Surgeon Dr. J P Kalita performed the complex surgery and saved a patient’s life. The surgery was performed on a 45-year-old female patient who had a hole in her heart and leakage of a heart valve.
Patient underwent a successful key hole surgery through chest wall rather than the conventional breast bone cutting open heart surgery. The main benefit of this surgery is minimal post-operative recovery time, less pain and minimal blood loss. Moreover, the chance of getting infected after the procedure is also comparatively very less. Any patient who undergoes minimally invasive cardiac surgery can resume their normal activities within two weeks. Patient recuperated well after the surgery and got discharged.
The Cardiac surgery team at Apollo Hospitals Guwahati is headed by Dr. J P Kalita. Dr. Kalita is an expert in Minimally Invasive Cardiac Surgery for both Adult and Paediatrics. At the advent of this new Cardiothoracic unit in Apollo Hospitals Guwahati, people of Assam and neighbouring states will also be highly benefitted.
Technology
Apollo Hospitals, Navi Mumbai performed a 3D printed titanium skull implant surgery to save the life of a trau...
Mr. Desai, a 41-year-old male, met with a road accident that resulted in a traumatic brain injury and was promptly taken to Apollo Hospitals, Navi Mumbai on September 15, 2018. When bought in, he was unconscious, with evident CSF rhinorrhoea and otorrhoea from left ear, and herniating brain tissue from the left nostril.
Once the patient was stabilized, he was taken for an urgent Craniotomy for evacuation of subdural Hematoma, intra-cerebral contusion, and repairing of the skull base. He was then moved to the ICU for recovery, which in view of the severe brain injury was slow. On October 29, 2018, he was finally discharged as his sensorium had improved.
The patient’s brain was allowed to heal for several months before the planned Cranioplasty. The team of doctors at Apollo Hospitals, Navi Mumbai, had to ensure the best possible cosmesis without major intraoperative manipulation of the skull base repair. The defect also covered a large part of the forehead extending to the bridge of the nose and the left supraorbital ridge – all of which had cosmetic implications. Hence, 3D-printed titanium implant was opted because it would closely replicate the shape of the patient’s skull. On January 9, 2019, the patient underwent Cranioplasty with the implant, after which he made a swift recovery and was discharged three days later.
3D-printed implants are beneficial for multiple reasons like it fits the patient’s form, MRI compatible and lesser chances of getting infection. In this case, first a CT scan helped make an identical 3D model of the skull in its current form. Then a titanium mesh was created to perfectly fit the skull. Once it was ensured that the implant was a perfect match for the patients’ structure, the neurosurgeons went ahead with the Cranioplasty.
Dr Sunil Kutty, Consultant, Neurosurgery, Apollo Hospitals, Navi Mumbai said, “It was a bad case of head injury and not many survive these kinds of injuries. His recovery was a team effort and we also had a challenge in the form of making his face and head look as normal as possible. After being admitted on September 15, 2018, Mr. Desai was in the hospital for about a month and half, before being discharged. After allowing the brain of patient to heal for several months, Cranioplasty (surgical repair of a defect or deformity of a skull) was undertaken. The team needed to ensure the best possible cosmesis without major manipulation of the skull base. A large part of the forehead extending to the bridge of the nose and part of the ridge was affected and had cosmetic implications. Therefore, we decided that a 3D printed titanium implant would be suitable to closely replicate the shape of the patient’s skull. On January 9, 2019, the patient was bought in for the Cranioplasty with the implant and was discharged three days later. 3D printed implants are MRI compatible, decrease the risk of infections and most importantly can be made to fit the patient’s form. Mr. Desai may take a couple of years for complete recovery, but he will soon get back to being a constructive part of the society.”
Clinical Excellence
Indraprastha Apollo Hospitals, Delhi successfully operated on a 6-month-old Kenyan baby with a rare heart defe...
At the tender age of six months, Emmanuel Lila Kamank, a Kenyan national, underwent open-heart surgery for a rare cyanotic congenital heart defect known as Taussig-Bing anomaly at Indraprastha Apollo Hospitals. Just four days after his birth, Emmanuel was diagnosed with this heart defect and as his condition worsened, he was referred to Apollo Hospitals, Delhi for surgery.
Dr. Muthu Jothi, Senior Consultant- Paediatric Cardiothoracic surgeon, Indraprastha Apollo Hospitals, New Delhi explains, “When Emmanuel came to Apollo, he was already cyanotic, which means that he had bluish discoloration of skin due to lack of oxygen in his blood. On examination, it was found that his respiratory rate was below normal at 20 breaths per minute. At the hospital, he suddenly underwent respiratory arrest. The attack was so severe that the child also had a cardiac arrest. His condition was pretty dire due to which he was put on ventilator and shifted to cardiac ICU.”
Dr. Jothi further stressed on the criticality of the baby’s condition, “The child was already diagnosed with Taussig-Bing anomaly, which is a malformation of the heart in which there is transposition of aorta to the right ventricle, which in normal cases should originate from left ventricle. At the same time, his pulmonary artery was also wrongly positioned into the right ventricle. This is called double outlet right ventricle defect. Upon further investigation, we found out that there was also an interrupted aortic arch (block in the aorta). On top of that, the child had large subpulmonary ventricular septal defect (VSD), atrial septal defect (ASD), and Patent ductus arteriosus (PDA), wherein ductus arteriosus, the blood vessel that is open when the child is inside the mother’s womb does not close due to this defect. In addition to all this, he also had a single coronary origin giving rise to right and left coronary arteries. The right coronary had a part inside the wall of the aorta which we call as intramural coronary artery. This makes it very difficult technically to relocate the coronary arteries into the new aorta. Needless to say, it was very high risk case with limited chances of success even with surgery. We devised a treatment plan for the baby, but informed his family about the 50-60% surgical risk associated with it. The family consented to the high risk and we decided to go ahead with the procedure.”
On 21st January 2019, the child underwent the surgery which was performed by Dr. Muthu Jothi and his team consisting of Dr. Manisha Chakrabarti, Senior Consultant Paediatric Cardiologist and Dr. Reetesh Gupta, Senior Consultant Paediatric intensivist.
Explaining the complexity of the surgery, Dr. Muthu Jothi said, “The procedure was done under total circulatory arrest, which means that the entire blood in circulation in his body was drained into the heart lung machine. Before that we had to cool the child’s body to 16 degrees Celsius. This is near freezing for the human body. We even put ice on the surface of his brain. Without circulation, we can keep the patient in this state for maximum of 45 minutes. Beyond that, there’s the risk of injury to the brain, spinal cord, kidneys and other organs. The total time Emmanuel was on total circulatory arrest was 30 minutes. During this time, we repaired the aortic arch interruption by tying off and disconnecting the PDA blood vessel and connecting it to the aortic arch.
After doing this, we put the child again on the heart-lung machine and did the switch operation to put the blood vessels in their correct position. The intramural coronary artery was a very difficult condition where we had to mobilise this blood vessel and re-implant it into the new aorta. During this process if there’s an error of even half a millimeter, if it doesn’t go exactly where it needs to go, the coronary artery’s blood supply will be reduced, which can cause a heart attack. This repair was followed by closure of ventricular septal defect (VSD) and atrial septal defect (ASD). It was a very long surgery lasting almost 9 hours.”
The operation was successful and the baby was shifted to the ICU in a stable condition but with his chest still open, “The chest was kept open for 24 hours because there was a lot of swelling in the heart once we did the operation. Once the swelling came down and the child started passing urine post 12 hours after the operation, we closed the chest in the ICU. After this, child stayed for nearly a week on the ventilator,” Dr Muthu explained.
Baby Emmanuel slowly recovered and was discharged on the 17th day from the hospital.
The parents of the baby expressed their gratitude to the team at Apollo Hospitals who successfully operated on baby Emmanuel and treated him, “By the grace of God and the tireless efforts of Dr. Muthu Jothi and his team, Emmanuel is now well and has a long life ahead of him. Our prayers have been answered at Apollo Hospital and we cannot thank the doctors enough for their dedication. They kept us motivated throughout the treatment process.”
Baby Emmanuel has now gone back to Kenya with his family and is doing well.
Clinical Excellence
Apollo Hospitals, Hyderabad has successfully performed Liver Transplant on a four-month-old baby
The doctors at Apollo Hospitals, Hyderabad have successfully performed Liver Transplant on a four-month-old baby. It was a challenging case for doctors to perform transplant surgery on such a small baby. There are only few hospitals worldwide, having the capability to perform liver transplants among children, weighing less than 5 kgs and below 6 months of age. At Apollo Hospitals, Hyderabad, the Pediatric Liver Transplant team has tremendous experience and expertise along with the technology to perform critical and delicate liver transplant surgeries in infants, said Dr Manish C Varma, Head of the Liver Transplant Department at Apollo Hospitals, Jubilee Hills.
In Vizag, the treating doctors performed a Porto-enterostomy surgery on the baby, to treat pediatric liver disease, where the bile ducts are abnormally narrow, blocked, or absent. The baby was only 2.5 months old when he underwent this surgery. However, even after the surgery, there was no sign of jaundice subsiding and the condition was further deteriorating. The doctors at Vizag recommended liver transplant and the baby was brought to Apollo Hospitals, Jubilee Hills.
On March 14, Liver Transplant surgery was performed and Mrs. Sarojini, mother of the baby, was the donor. Post-operatively the baby recovered well and was discharged nine days after surgery on March 23. The donor was discharged on March 19.
“There is a need for spreading awareness that however small and underweight the baby is, it can be treated with a liver transplant if it is needed,” said Mr. Y Subramanyam, CEO Apollo Hospitals.
The complicated liver transplant was carried out by a multidisciplinary team consisting of Dr Ramesh Srinivasan, Pediatric Hepatologist, Dr L Sasidhar Reddy, Transplant Surgeon, Dr Manjunath and Dr Vijay, Anesthetists and Intensivists respectively and Dr Samiya Razvi, Pediatric Pulmonologist, at Apollo Hospitals, Hyderabad.
Clinical Excellence
Apollo Gleneagles Hospitals, Kolkata is the first hospital in the Eastern region to introduce TARE, a latest t...
Apollo Gleneagles Hospitals brings TARE (Trans Arterial Radio Embolization), the latest treatment for liver cancers for the first time in Kolkata. It is the only option and hope for a special set of patients, who are actually quite large in number. TARE is a procedure, where using special instruments and micro-catheters, the identified source of blood supply to the tumor in liver is accessed and intra-arterial radiotherapy is delivered using Yttrium-90 (Radiotherapy agent). This results in significant improvement and at times complete treatment of the tumor as well, giving new lease of life to these patients.
The TARE procedure requires special permission for the hospital to perform it with multiple other considerations. Mr Rana Dasgupta, CEO Apollo Gleneagles Hospitals Kolkata, expressed “We at Apollo Gleneagles Hospital are happy to announce that honouring our commitment to deliver the best healthcare and innovative procedures for our patients; we have started performing TARE, which would benefit our patients substantially. With this, Apollo Gleneagles Hospital, Kolkata becomes the first corporate multispecialty hospital in the East to perform this procedure.”
Present at the occasion, Dr Manash Saha, Senior Consultant, Vascular & Non-Vascular Intervention, Apollo Gleneagles Hospitals Kolkata expressed, “The first TARE procedure performed in Apollo Gleneagles Hospital was for a patient of multiple colorectal metastasis which was progressive in nature and was not responding despite two separate lines of chemotherapy.”
He also mentioned, “Primary liver cancers, particularly hepatocellular carcinoma (HCC) and extensive metastasis or secondary deposits in the liver pose a great clinical challenge to treat, especially if they are progressive in nature despite all kinds of treatment. With a huge and increasing burden of Hepatitis B and C patients, the HCCs are in rise.
Hepatocellular carcinoma, however, poses a completely different degree of challenge to treat . Usually they are detected when quite big in size and not possible to treat by any other means. Many a times they are detected with the tumor thrombus progression in the main blood supply to the liver that is the portal vein, which makes them inoperable or untreatable. Even small lesions in the liver peripherally can present with the malignant portal vein thrombosis rendering these patients untreatable even if they are completely preserved functionally in presentation.
TARE procedure is considered as the pinnacle of intervention and with this, AGHL is now equipped with the full set of interventional radiology treatments to patients of liver cancer whenever required. The entire range of treatment is now available under one roof in AGHL, Kolkata starting from ablative therapies like radiofrequency and microwave ablation to TACE (transarterial chemoembolization) – both conventional as well as DEB (drug-eluting bead) TACE along with TARE.
The TARE procedure is done in two sittings where in the first sitting, the tumor is identified by angiographic evaluation and any potential source of extrahepatic organs are embolized to reduce the chances of radiotherapeutic agents going to other organs. Following this, the dose is calculated and prepared usually in Canada or Singapore from where the dose is transported in a premeasured amount and delivered on specific dates using a special system in the Cath lab.
Clinical Excellence
A 45-year-old patient successfully underwent third kidney transplant at Indraprastha Apollo Hospitals, Delhi
‘No matter how hard life is, don’t lose hope’ – The saying stands true for 45-year-old Etika Kalra, a resident of Delhi, who underwent a third kidney transplant at Indraprastha Apollo Hospitals. This time, her husband donated his kidney to save her life. Even though they were ABO incompatible, which means that their blood groups did not match, due to the skilled expertise of Padma Shri awardee Dr. (Prof) Sandeep Guleria, Senior Consultant, General Surgery, GI Surgery and transplantation, Indraprastha Apollo Hospitals and his team, the highly complicated transplant was performed successfully. Dr. Guleria performed the earlier kidney transplants as well.
In 1996, when she was 23 years old and recently married, Ms. Kalra found out, during a routine check-up, her kidneys were shrinking. She was diagnosed with Glomerulonephritis, a type of disease in which the part of kidney which filters blood (called glomeruli) becomes damaged. Since that time, Ms. Kalra has been constantly fighting a battle with this disease. Initially, she explored various Ayurvedic treatments to treat her condition, but there was no relief and the creatinine levels in her blood continued to rise. In December 2000, she had to start regular dialysis as her kidneys were no longer functioning properly. Ms. Kalra underwent her first kidney transplant in 2001 where her elder sister Anshoo Walia donated her kidney. For more than a decade the donated kidney served Ms. Kalra well, but the life of a donated organ is limited. By 2014, she again started facing kidney problems.
“By the time we found out that her first kidney was failing, it was too late to start her on dialysis. Her health was deteriorating fast and so we opted for a pre-emptive transplant. This time, her other sister, Ritu Pahwa, donated a kidney,” Dr. Guleria said, explaining the procedure and the unexpected complications which arose after. “A few days after her second transplant, while Ms. Kalra was still in ICU, she started complaining of severe stomach pain. It was found that she had gangrene of intestine for which we had to do an immediate major abdominal surgery to save her life. This was while she was still recovering from her second kidney transplant and it made her quite weak.”
Unfortunately, the second kidney was functional only for about 4 years after which it started failing. “It was a case of acute antibody rejection of the transplanted organ, in which Ms. Kalra’s own immune system started attacking the kidney. There were only two viable options for her at that time – either live on dialysis for the rest of her life or undergo another kidney transplant. Ms. Kalra chose the latter and this time her husband, Tarun came forward to donate his kidney. We counselled the family about the various risks involved with this surgery, after which they gave us consent to go ahead. Their blood groups did not match so to overcome the ABO incompatibility; we did numerous plasma exchanges. The first two transplants took about three hours but the third transplant took five and a half hours since the third operation was technically more difficult. However, we successfully overcame that barrier and transplanted the third kidney.”
In regards to Ms. Kalra’s incredible story, Dr. Guleria said, “Etika’s body is responding well to the new kidney and we hope that this time it will last for the rest of her life. Surviving three kidney transplants takes an incredible amount of strength, endurance and faith. She did not lose hope and her strong will to live pushed her to not give up at any point. Her family support was unwavering throughout.”
Ms. Kalra is now doing well and wants that her story motivates others to not give up in the face of adversity, “When the option of kidney transplant for the third time was presented to us, it came as a surprise. For a layman, two kidney transplants are rare. But Dr. Guleria explained that kidney transplant is possible even for the third time and one can lead a normal life after that. He apprised us of all the possible complications. But since he had already performed the kidney transplants twice on me before, I had full faith in him and knew that my life was in the hands of an experienced and trusted doctor. After all these years, Dr. Guleria is like family to us now, and his guidance and support has been invaluable. My children are the source of my inspiration who keep me going,” said Ms. Kalra.
“Even after the third transplant, the precautions I have to take are the same as before. The food I eat has to be hygienic and freshly prepared. Eating outside should be avoided, and it is essential to have medicine on time,” Ms. Kalra said.
Technology
Apollo Hospitals Group and Zebra Medical Vision (Zebra-Med) collaborate to validate and deploy AI (artificial ...
Global Innovation & Technology Alliance (GITA) on behalf of Department of Science & Technology, Government of India and Israel Innovation Authority (IIA), on behalf of Government of Israel, granted HealthNet Global, a part of the Apollo Hospitals Group, India and Zebra Medical Vision, Israel funding to validate, co-develop and deploy medical imaging Artificial Intelligence (AI) across India and to increase Tuberculosis (TB) screening capabilities in the rural areas.
HealthNet Global (HNG), a part of the Apollo Hospitals Group, India and Zebra Medical Vision (Zebra-Med), one of the global leaders in AI Imaging software, Israel announced a new collaboration that will focus on validating and deploying AI based tools at scale across India. The companies shall jointly receive support from India-Israel Industrial R&D and Technological Innovation Fund (I4F) for their $4.9 Million project to co-develop and to provide clinical validation, and evidence of the efficacy of radiology Al based tools in India as per I4F norms.
The final developed project will be able to assist as a primary screening method for major diseases in large scale screenings. For example, World Health Organization (WHO) estimates that 3.6 million people with TB are missed by health systems every year and do not receive adequate care. This is primarily because patients with TB may present with mild or no symptoms, particularly early on. Many affected people arrive at clinics too late with advanced disease or multi-drug resistant TB (MDR-TB), which is difficult to treat and more likely to cause death. One of the key strategies to tackling TB is early diagnosis. Unfortunately, sputum testing is only 50% accurate and frequently misses the disease in its early stages. Both companies will focus on development of AI-based Chest X-ray interpretation tool for TB which can help address the gap.
Speaking of the initiative, Sangita Reddy, Joint Managing Director, Apollo Hospitals said “When it comes to health, the promise of AI to provide access and improve outcomes in very intriguing. There is a critical need to provide good healthcare access in remote and rural communities, and we believe this initiative will allow us the opportunity to make significant advances in this area. Apollo’s clinical and scientific depth and Zebra-Med’s expertise in AI complement each other perfectly. This project is part of our continuing endeavour to design new tools to improve healthcare access and deliver best outcomes to patients at lower cost.”
In addition to leveraging clinical depth and breadth of the Apollo Hospitals network, HNG will work in close collaboration with Apollo Radiology International, a distinguished part of Apollo Hospitals, to bring in leadership, experience and technology in Radiology reporting to the project. The partnership will capitalize on the advancements already achieved by Zebra-med in developing dozens of AI tools. The arsenal of algorithms will include deep learning algorithms for the detection of acute conditions such as brain bleeds in head CTs and Pneumothorax in chest X-ray, detection of breast cancer in mammograms, Osteoporosis in CT scans and 40 other conditions.
“We are excited to partner with the leading healthcare services provider in India and to help bring AI to India at such a scale,” noted Eyal Gura, Co-founder and CEO of Zebra-Med. “When we met the Indian team for the first time few years ago we found common ground and similar dream of scaling healthcare from millions to billions of patients. We are honored that the two governments have placed their trust in us and we are committed to utilize this opportunity to impact millions of lives.”
The grant will aid the partners to focus on development of India specific algorithms tool which would be of immense benefit to patients across India and other emerging nations. The project will also modify existing algorithms to make them suitable for the Indian population. The final product will assist provide high quality radiology access to remote locations by alerting the presence of critical findings immediately. This will help provide timely, cost-effective, quality care to patients in remote and rural locations.
“This is an exciting time for AI in medicine,” said Vikram Thaploo, CEO of HNG. “As these systems increase in accuracy, so will the viability of using AI to extend the reach of Chest X-Ray interpretation, improve reporting efficiency and save lives. We believe in the impact that technology can have in helping provide timely, cost-effective, quality care to patients in remote locations and our partnership with Zebra-Med is a step in this journey.”
“We believe that this project will be a very important milestone in the introduction of AI in Indian healthcare. We are excited to provide clinical leadership and expertise to this initiative”, said Dr. Sreenivasa Raju Kalidindi, CEO and Medical Director of Apollo Radiology International.
Milestones
Apollo Hospitals Group has been honored with a postal stamp for successful completion of 20 million health che...
The Apollo Hospital Group announced the formal release of a postal stamp on Preventive Healthcare by Shri Banwarilal Purohit, Hon’ble Governor of Tamil Nadu. The commemorative stamp honours and acknowledges the Chairman of Apollo Hospitals; Dr. Prathap C Reddy’s pioneering efforts in encouraging preventive healthcare in India.
Shri R Anand, Postmaster General, Chennai City, Ms. Preetha Reddy, Vice Chairperson Apollo Hospitals and Ms. Suneeta Reddy, Managing Director, Apollo Hospitals attended the special occasion at the Raj Bhavan, Chennai
Over thirty-five years ago, in 1983, Dr. Prathap C Reddy had established Apollo Hospitals, India’s first corporate hospital to make advanced medical care accessible to all in the nation. Since then, Apollo Hospitals’ pioneered innumerable initiatives in healthcare management and amongst them, one was the launch of the ‘Master Health Check’, which introduced a culture of preventive healthcare into India. Cognizant of the intrinsic value of good health, Dr. Reddy has been empowering and encouraging fellow Indians to live healthy and screen regularly to diagnose disease early, particularly vital to conquer cancer.
Speaking on the occasion, the Hon’ble Governor of Tamil Nadu, Shri Banwarilal Purohit said, “Dr. Reddy and Apollo are synonymous with Healthcare excellence in the world. They excel in end to end healthcare of consumers from 140 plus countries and have many firsts including the recent launch of South East Asia’s first ever Proton Cancer Care Therapy centre. Preventive Care was first pioneered in India by Dr Prathap Reddy and today I am happy to commend his dedication to Disease Prevention through this special stamp.”
Ms. Preetha Reddy, Vice Chairperson of Apollo Hospitals said “Our Chairman, Dr. Prathap C Reddy’s dream is to do all that is needed to ensure that everyone has good health and happiness. His life’s objective has been to not just make advanced medical care accessible to patients, but also, to prevent the onset of disease. Apollo’s Preventive Healthcare initiatives have been working tirelessly for almost four decades to ensure that his dream is realised. We take pride in having touched 20 million lives through our preventive healthcare endeavours. It is a very significant moment for the entire Apollo family, as a special preventive healthcare commemorative stamp is being released, in recognition of our efforts”.
Shri Alok Ojha, Senior Superintendent of Post Offices, congratulated Dr. Prathap C Reddy, Founder and Chairman, Apollo Hospitals Group & his team for successful completion of 20 million health checks & delivering excellence in health services for past 36 years. Such commendable services have set a world record in Preventive Health Checks.
New Initiatives
Apollo Hospitals Group has offered free treatment to the injured Central Reserve Police Force (CRPF) troopers ...
On February 15, 2019, Apollo Hospitals Group has offered free treatment to the injured troopers of the Central Reserve Police Force (CRPF), who survived the terror blast in Pulwama district’s Awantipora town, Kashmir on February 14, 2019.
“We offer to treat the CRPF troopers injured in the terror attack till recovery and rehabilitation at any of our hospitals across the country,” said Dr. Prathap C. Reddy, Founder and Chairman, Apollo Hospitals Group.
Grieving the loss of 45 brave troopers, Dr. Prathap C. Reddy hailed the martyrs who laid their lives for the country and offered condolence to their bereaved families.
“We salute the families of the victims who gave the country such brave sons of the soil and for their supreme sacrifice,” added Dr. Prathap C. Reddy.
Best Hospital Near me Chennai
